Resmed Inc
RMD
View Detailed Chart
257.610USD
-0.110-0.04%
Close 01/29, 16:00（ET）Quotes delayed by 15 min
37.60BMarket Cap
26.26P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.04%
5 Days
+0.89%
1 Month
+6.08%
6 Months
-7.23%
Year to Date
+6.95%
1 Year
+1.88%
View Detailed Chart
TradingKey Stock Score of Resmed Inc
Currency: USD Updated: 2026-01-29Key Insights
Resmed Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 8 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 292.76.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Resmed Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Resmed Inc Highlights
StrengthsRisks
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.15B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.
Undervalued
The company’s latest PE is 26.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 95.97M shares, decreasing 1.42% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 17.10K shares of this stock.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
292.763
Target Price
+14.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Resmed Inc Info
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Ticker SymbolRMD
CompanyResmed Inc
CEOFarrell (Michael J)
Websitehttps://www.resmed.com/
Related Instruments
-0.59%
-2.61%
+0.04%
-2.78%
-2.19%
-1.56%
-0.99%
+0.21%
-1.77%
+0.55%
+1.50%
-0.41%
+0.45%
-1.33%
-0.41%
-1.60%
-0.45%
+0.91%
-0.45%Popular Symbols
258.280
+1.840 (+0.72%)
192.510
+0.990 (+0.52%)
83159.770
-1019.180 (-1.21%)
278.410
-1.290 (-0.46%)
2764.860
-38.490 (-1.37%)
416.560
-14.900 (-3.45%)
5211.680
-181.920 (-3.37%)
64.073
-1.165 (-1.79%)
1.193
-0.004 (-0.32%)
153.908
+0.796 (+0.52%)
